Award, April 2 -- winning Australian bioanalytical laboratory Agilex Biolabs announced on 2 April 2020 that it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.

More than 38% of Agilex Biolabs' biotech clients already come from the APAC region - primarily from China and South Korea.

APAC clients are particularly attracted by Agilex Biolabs' FDA-inspected status, and the more than 40% rebate on clinical trial spend that applies in Australia.

Agilex Biolabs specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments.

Agilex Biolabs, the only FDA-inspected lab of its type in th...